Iovance Biotherapeutics (IOVA) Share-based Compensation (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted Share-based Compensation of $11.73 million for Q2 2026, down 21.5% from $14.94 million a year earlier but up 4.1% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Iovance Biotherapeutics was $46.72 million, down 53.2% year-over-year; for FY2025, it came in at $61.58 million, down 43.8% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- In prior years, Iovance Biotherapeutics' Share-based Compensation was $109.63 million in FY2024 (+75.1%), $62.63 million in FY2023 (-25.5%), $84.02 million in FY2022 (+20.4%) and $69.77 million in FY2021 (+70.6%).
- Quarterly Share-based Compensation has run from a low of $11.27 million in Q1 2026 to a high of $31.01 million in Q3 2024 over five years.
- On a year-over-year basis, Share-based Compensation has declined in each of the last five quarters, with an average decline of 0.3% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2024, with growth of 115.1%; the weakest was Q4 2025, with a decline of 61.9%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $11.27 million (Q1 2026), $11.82 million (Q4 2025) and $11.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | 11.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.73 Mn |
| Mar 31, 2026 | 11.27 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 14.94 Mn |
| Mar 31, 2025 | 22.92 Mn |
| Dec 31, 2024 | 30.98 Mn |
| Sep 30, 2024 | 31.01 Mn |
| Jun 30, 2024 | 30.47 Mn |
| Mar 31, 2024 | 17.18 Mn |
| Dec 31, 2023 | 14.40 Mn |
| Sep 30, 2023 | 15.82 Mn |
| Jun 30, 2023 | 16.74 Mn |
| Mar 31, 2023 | 15.67 Mn |
| Dec 31, 2022 | 19.51 Mn |
| Sep 30, 2022 | 19.78 Mn |
| Jun 30, 2022 | 22.47 Mn |
| Mar 31, 2022 | 22.27 Mn |
| Dec 31, 2021 | 19.10 Mn |
| Sep 30, 2021 | 19.31 Mn |
API Access
Iovance Biotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();